Literature DB >> 19962630

Criterion contamination of depression scales in patients with rheumatoid arthritis: the need for interpretation of patient questionnaires (as all clinical measures) in the context of all information about the patient.

Theodore Pincus1, Afton L Hassett, Leigh F Callahan.   

Abstract

The validity of information on a patient questionnaire may not necessarily be generalizable to all individuals and situations, and may depend on the context in which a person provides the information. Examples may be seen in responses of people with rheumatoid arthritis on the Minnesota Multiphasic Personality Inventory (MMPI), on the original Beck Depression Inventory (BDI), and on the Centers for Epidemiologic Studies Depression Scale (CES-D). Several reports have indicated tendencies toward hypochondriasis, depression, and/or hysteria on the MMPI, and tendencies toward depression on the original BDI and CES-D. However, these interpretations were based in large part on responses to such statements as "I am in just as good physical health as most of my friends," "I can work about as well as before," and "I could not get going." These responses would suggest psychological concerns in people who have no somatic disease, the type of subjects in whom these scales were validated, but would also appear appropriate for people with rheumatoid arthritis, including those with no psychological problems. Rheumatologists confirmed independently the likelihood that people with rheumatoid arthritis would respond differently from the general population in responding to these and other statements. This phenomenon, known as criterion contamination, would explain much, but not all, of elevations in scores on these scales in patients with rheumatoid arthritis. The BDI was revised in 1996, as the Beck Depression Inventory-II (BDI-II), to eliminate the items reflecting somatic disease.

Entities:  

Mesh:

Year:  2009        PMID: 19962630     DOI: 10.1016/j.rdc.2009.10.015

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

1.  Medial branch neurotomy in low back pain.

Authors:  Salvatore Masala; Giovanni Nano; Matteo Mammucari; Stefano Marcia; Giovanni Simonetti
Journal:  Neuroradiology       Date:  2011-10-18       Impact factor: 2.804

2.  [Depression as a systemic feature of rheumatoid arthritis].

Authors:  M Englbrecht; J Wendler; R Alten
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

3.  Screening for depression in arthritis populations: an assessment of differential item functioning in three self-reported questionnaires.

Authors:  Jinxiang Hu; Michael M Ward
Journal:  Qual Life Res       Date:  2017-06-17       Impact factor: 4.147

4.  Treatment of painful Modic type I changes by vertebral augmentation with bioactive resorbable bone cement.

Authors:  Salvatore Masala; Giovanni Carlo Anselmetti; Stefano Marcia; Giovanni Nano; Amedeo Taglieri; Eros Calabria; Marcello Chiocchi; Giovanni Simonetti
Journal:  Neuroradiology       Date:  2014-05-01       Impact factor: 2.804

5.  Depression Subtypes in Individuals With or at Risk for Symptomatic Knee Osteoarthritis.

Authors:  Alan M Rathbun; Megan S Schuler; Elizabeth A Stuart; Michelle D Shardell; Michelle S Yau; Joseph J Gallo; Alice S Ryan; Marc C Hochberg
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05       Impact factor: 4.794

6.  Psychometric Testing of the Chinese-Version Glover-Nilsson Smoking Behavioral Questionnaire (GN-SBQ-C) for the Identification of Nicotine Dependence in Adult Smokers in Taiwan.

Authors:  Shu-Ching Chen; Hsiu-Fang Chen; Hsi-Ling Peng; Li-Yun Lee; Ting-Yu Chiang; Hui-Chuan Chiu
Journal:  Int J Behav Med       Date:  2017-04

7.  Exercise - induced changes in cerebrospinal fluid miRNAs in Gulf War Illness, Chronic Fatigue Syndrome and sedentary control subjects.

Authors:  James N Baraniuk; Narayan Shivapurkar
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

8.  Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis.

Authors:  Carol A Hitchon; Lixia Zhang; Christine A Peschken; Lisa M Lix; Lesley A Graff; John D Fisk; Scott B Patten; James Bolton; Jitender Sareen; Renée El-Gabalawy; James Marriott; Charles N Bernstein; Ruth Ann Marrie
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-07-08       Impact factor: 4.794

Review 9.  Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease.

Authors:  Kirsten M Fiest; Charles N Bernstein; John R Walker; Lesley A Graff; Carol A Hitchon; Christine A Peschken; Ryan Zarychanski; Ahmed Abou-Setta; Scott B Patten; Jitender Sareen; James Bolton; Alexander Singer; Ruth Ann Marrie
Journal:  BMC Res Notes       Date:  2016-08-12

10.  Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.

Authors:  Ruth Ann Marrie; Lesley Graff; John R Walker; John D Fisk; Scott B Patten; Carol A Hitchon; Lisa M Lix; James Bolton; Jitender Sareen; Alan Katz; Lindsay I Berrigan; James J Marriott; Alexander Singer; Renée El-Gabalawy; Christine A Peschken; Ryan Zarychanski; Charles N Bernstein
Journal:  JMIR Res Protoc       Date:  2018-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.